GE HealthCare Technologies, Inc. (NASDAQ: GEHC) is a global medical technology and life sciences company that develops and delivers diagnostic imaging, radiotherapy, digital solutions and biopharmaceutical manufacturing technologies. Its product portfolio includes advanced magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, molecular imaging and X-ray systems, along with interventional and surgical imaging equipment designed to enhance diagnostic accuracy and patient care.
Beyond hardware, GE HealthCare provides software platforms that enable clinical data management, workflow optimization, artificial intelligence–driven analytics and remote patient monitoring. Its life sciences division supplies single-use technologies, cell therapy tools and customized processing systems for biopharmaceutical research, development and manufacturing, supporting pharmaceutical customers in bringing therapies from concept to commercialization.
Headquartered in Chicago, Illinois, GE HealthCare serves healthcare providers, research institutions and pharmaceutical companies in more than 160 countries through a combination of direct sales, service operations and channel partners. The business traces its origins to the early days of commercial X-ray and evolved as part of General Electric’s Healthcare division before becoming an independent public company in early 2023. Under the leadership of CEO Peter Arduini, the company continues to expand its global footprint and invest in innovation to address evolving healthcare challenges.